Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Available at: www.fda.gov/media/131878/download. Epilepsy Behav.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 1, 2021

In countries where medical cannabis is legal, patients have more treatment options to choose from. Patients in the UK who are suffering from epilepsy, multiple sclerosis, insomnia, chronic pain, anxiety, and other medical conditions can use medical cannabis as an adjunct or alternative treatment.

Legalization 109

Legalization Marijuana Treatment Patients 109

Cannabis Law Report

JULY 24, 2019

Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. We have the expertise to prescribe medicinal cannabis in a way that fits in with other more conventional treatments as and when we judge that to be in the best interest of the patients.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Theodore happens to also be an addiction expert who refuses to provide treatment to patients that choose to consume cannabis as he believes it interferes with the treatment of other addictions.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. This guide aims to demystify the process, offering practical advice and insights to help patients make informed decisions.

Dispensary 52

Dispensary Patients Marijuana Education 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

MMJ Recs

NOVEMBER 28, 2022

Image by Kindel Media on Pexels : How do dispensaries work in WV? . Every West Virginia Dispensary That MMJ Patients Need To Know. They state that “patient visits at BCC are designed to be experiential and interactive – as quick and seamless or leisurely and educational as desired by the patient. Parkinson’s disease.

Dispensary 52

Dispensary Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. The Altoona Mirror reports.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

AUGUST 21, 2019

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Epilepsy Cannabinoids THC 74

Veriheal

OCTOBER 1, 2020

In 2018, the government was confronted by a media storm that has called for them to act. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy. As a result, the UK proposed medicinal cannabis regulations in 2018. .

Legalization 105

Legalization Oil Medicine Media 105

MMJ Recs

NOVEMBER 24, 2023

Virginia’s journey into the world of medical marijuana (MMJ) has been a significant development, offering patients a range of therapeutic options to address various health conditions. It is commonly used to manage conditions such as epilepsy, chronic pain, and anxiety. They are favored by patients seeking long-lasting relief.

Strains 52

Strains Chronic Pain Indica Patients 52

CannaMD

AUGUST 19, 2020

While COVID-19 can be deadly, the World Health Organization (WHO) stresses that most patients experience mild cases and/or survive: Most people who get COVID-19 have mild or moderate symptoms and can recover thanks to supportive care. Note: Study extracts were applied via media. ” And their alternative strategy of choice?

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Sensi Seeds

JANUARY 7, 2019

Not only is Simply Pure the first Colorado dispensary run by African-Americans, it’s also known for its political activism, with James and her husband, Scott Durrah, a former marine and certified chef, actively campaigning for the rights of cannabis patients and ex-army vets suffering from PTSD. Joshua Kaplan.

Education 94

Education Dispensary Media Cannabis 94

The Herb Collective

DECEMBER 1, 2022

Marijuana has long been demonized in the media and by law enforcement due to its psychoactive properties. However, there has been an increasing amount of research in recent years that suggests medical marijuana can have a number of positive benefits for patients suffering from various ailments. Seizure Control.

Chronic Pain 52

Chronic Pain Nerve Pain Marijuana Sleep 52

Veriheal

JULY 2, 2020

However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. The original bill as drafted would have only opened the door to patients that had suffered a traumatic brain injury or a concussion.

Banking 52

Banking Programs Therapy Conditions 52

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: The Guardian ). Source: SIPSE.COM ).

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

TheAnswerPage

SEPTEMBER 16, 2019

Urine drug tests typically screen for the patient’s prescribed opioids and the commonly abused drugs: cocaine, amphetamines, alcohol, barbiturates, opiates and benzodiazepines.Although a urine drug test can confirm if the patient is taking the prescribed opioid, it cannot determine if the patient is taking the prescribed dose.

Epilepsy 40

Epilepsy Media Patients Education 40

CannaTech

MARCH 29, 2019

Last year, after much lobbying by and on behalf of Alfie Dingle and Billie Caldwell (The British Charlotte Figi), on November 1, 2018, specialist doctors were approved to prescribe various forms of marijuana for patients suffering from a range of ailments. The UK is the World’s Largest Cannabis Exporter. Only specialist (sic.

Chronic Pain 50

Chronic Pain Access Patients Food 50

MMJ Recs

APRIL 5, 2022

Seed banks have opened across the state and many Missouri MMJ patients are taking the opportunity to grow their own private supply of high-quality medical marijuana. A maximum of two license-holders can grow their marijuana in one location (these people can be two patients, a patient and a caregiver, or two caregivers).

Cultivation 52

Cultivation Banking Treatment Chronic Pain 52

Kind Meds (Cannabis Education Blog)

JUNE 27, 2021

Cannabis cigarettes were even advertised in popular media at the time. Medical cannabis can be used for a multitude of different reasons in patients: Chronic pain. Epilepsy and seizures. This makes cannabis a great alternative option to opioids if a patient is worried about forming a dependency. Nerve pain.

Pharmaceutical 99

Pharmaceutical Chronic Pain Medicine Nerve Pain 99

TheAnswerPage

SEPTEMBER 9, 2019

Is it common for HIV/AIDS patients to use cannabinoids for medicinal purposes? Press/Media. Answer of the Day. was successfully added to your cart. Course Catalog. Team Training. Answer of the Day. Today’s Answer of the Day. Leah Roach. September 10, 2019. Comprehensive Curriculum. Register Log in. Entries RSS. Comments RSS.

Epilepsy 40

Epilepsy Cannabinoids Media Education 40

TheAnswerPage

SEPTEMBER 7, 2019

the half-life of the discontinued drug is short and the half-life of the new drug is long, the patient can potentially experience breakthrough pain.Also, if the half-life of the discontinued drug is long and the half-life of the new drug is short, the patient may receive too much opioid at the time of opioid conversion. Press/Media.

Epilepsy 40

Epilepsy Media Education Safety 40

MMJ Recs

MAY 29, 2024

For many patients, traditional treatment options may fall short of providing relief from debilitating symptoms. Medical cannabis can provide relief from chronic pain, nausea, muscle spasms, and other symptoms commonly experienced by patients with conditions, such as cancer.

Marijuana 52

Marijuana Programs Patients Conditions 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. This article analyses media representations of medicinal cannabis in Australian medical publications. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

TheAnswerPage

SEPTEMBER 18, 2019

Nabiximols (a cannabinoid medicine containing THC and CBD) is approved in Europe for the treatment of neuropathic pain, spasticity and bladder dysfunction in patients suffering from multiple sclerosis. Press/Media. September 19, 2019. What are the potential drug interactions between nabiximols and analgesic medications? Entries RSS.

Epilepsy 40

Epilepsy Media Education Treatment 40

The Cannigma

JANUARY 31, 2021

He said the organization also encourages members to take part in charity events (like 10k and 5k runs) that raise money and awareness for diseases that cannabis can potentially help treat, such as multiple sclerosis , cancer , and epilepsy. Cannabis simply reminds me to slow it down and stay patient.”. Is working out high easier?

THC 145

THC Cannabis Environment CBD 145

Cannabis Law Report

JULY 15, 2022

Sunshine Coast based Tikun Oceana, formerly known as Medifarm , is now under the control of administrators from Cor Cordis.The company was founded …… Predictably Murdoch media has this behind a paywall if you want to pay to learn more. Media event date: 27 August 2019. Media type: Transcript. Thank you.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

JANUARY 13, 2020

We are proud of the positive impact this medicine has already had on thousands of patients and believe that this past year provides a compelling foundation for continued success in 2020,” said Justin Gover, GW’s Chief Executive Officer. Media Enquiries: Sam Brown Inc. media enquiries. Work with U.S. Enter long-term care segment.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Puff Puff Post

MARCH 2, 2020

(Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp. Web Site: [link].

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Cannabis Law Report

MARCH 6, 2020

KLS-13019 has not been reviewed or approved for patient use by the U.S. CMW Media. This is the sixth patent grant that Kannalife has received. Food and Drug Administration (FDA) or any other healthcare authority in the world. It’s safety and efficacy have not been confirmed by FDA-approved research. About Kannalife, Inc.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Cannabis Law Report

SEPTEMBER 10, 2019

Instead, CBD is fast garnering a reputation in the medical world as a potentially soothing treatment for conditions like arthritis, epilepsy , mental stress, or muscle pain, even as for certain forms of cancer.). They are to relieve chemotherapy-induced nausea and vomiting, epilepsy, multiple sclerosis, and chronic pain.

CBD 45

CBD Wellness and Beauty Banking Epilepsy 45

Cannabis Law Report

NOVEMBER 10, 2021

Cannabidiol (CBD) oil has grown in popularity over the years, with the media considering it as an add-in booster. Additionally, when a diabetes drug interferes with CBD, it may cause diarrhea in a patient. CBD has been legalized in all states, except three, making it readily obtainable. May Cause Injury To The Liver.

Oil 52

Oil CBD Research and Development Chronic Pain 52

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

FEBRUARY 1, 2020

There are now over 1,000 registered patients receiving medical marijuana products by prescription, and this number is projected to surge to 400,000 by 2028. Given single Australians under 35 years old spend about A$849/week total, such high expenditures on marijuana could amount to 25%+ of an epileptic patient’s monthly budget.

Legalization 59

Legalization Research and Development Recreational Access 59